Pf�nex, Inc.
(NYSE Amex Equities : PFNX)

( )
PFNX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.31%195.651.3%$518.42m
GILDGilead Sciences, Inc.
-0.27%65.780.9%$349.57m
ALXNAlexion Pharmaceuticals, Inc.
2.61%105.672.0%$327.78m
ILMNIllumina, Inc.
0.72%305.203.5%$315.92m
BIIBBiogen Inc.
0.19%235.621.3%$306.06m
CELGCelgene Corporation
0.28%98.951.3%$294.56m
AAgilent Technologies, Inc.
0.59%78.031.6%$175.77m
VRTXVertex Pharmaceuticals Incorporated
0.93%176.141.9%$174.75m
REGNRegeneron Pharmaceuticals, Inc.
0.38%286.152.6%$166.38m
SRPTSarepta Therapeutics, Inc.
2.02%85.3614.6%$145.24m
EXASExact Sciences Corporation
-1.94%103.4024.1%$138.75m
ACADACADIA Pharmaceuticals Inc.
-1.14%41.6813.9%$125.44m
INCYIncyte Corporation
-0.54%78.122.5%$85.20m
ALDRAlder Biopharmaceuticals, Inc.
-0.27%18.6610.2%$76.41m
BMRNBioMarin Pharmaceutical Inc.
0.66%76.004.3%$75.62m

Company Profile

Pfênex, Inc. is a clinical-stage biotechnology company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes biosimilars and vaccines. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.